Skip to Main Content

Paper Details

Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD.
Cell Stem Cell
13
2023
Author NameAffiliation
H??kan WidnerSkane University Hospital
Roger A BarkerUniversity of Cambridge, UK Wellcome-MRC Cambridge Stem Cell Institute
  • 1 - 2

Datasets

Release 1.2